The MTT assay demonstrated that upregulation of YAP1/SP1 significantly induced proliferation and enhanced 5FU resistance in CRC parental cells, whereas downregulation of YAP1/SP1 relatively reduced cell proliferation and drug resistance in CRC 5FU-resistant cells (Figure 6A, 6B). This evidence concerns the gene YAP1 and colorectal carcinoma.